Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Summary

The goal of this clinical research study is to learn if bendamustine can help to control Acute Lymphoblastic Leukemia/Lymphoma (ALL). The safety of this drug will also be studied. Bendamustine is designed to damage and destroy the DNA of cancer cells, which may cause them to die.

Timeline

Start

2012-12

Primary completion

2018-12

Completion

—

Drugs

Indications